-
August 11, 2020 Lupin Launches Zileuton Extended-Release Tablets
-
August 6, 2020 Lupin’s Alliance Partner Concord Receives U.S. FDA Approval for Mycophenolate Mofetil Tablets USP
-
August 6, 2020 Lupin Signs Exclusive Distribution Pact with ForDoz Pharma for 2 Complex Injectable Assets Under Development
-
August 6, 2020 Lupin Quarter 1 FY2021 Results
-
August 5, 2020 Lupin Launches Favipiravir Drug Covihalt® for Treatment of Mild to Moderate COVID-19
-
August 5, 2020 Lupin Launches Favipiravir Drug Covihalt® for Treatment of Mild to Moderate COVID-19
-
August 4, 2020 Lupin Receives Tentative Approval for Empagliflozin Tablets
-
July 26, 2020 Notice to the shareholders
-
July 23, 2020 Lupin AGM E-Voting Notice
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications